X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/05/26/2236903/0/en/Knight-Therapeutics-Announces-Closing-of-Previously-Announced-Acquisition-and-Exclusive-License-to-Exelon-in-Canada-and-Latin-America.html#:~:text=(TSX%3A%20GUD)%20(%22,as%20well%20as%20an%20exclusive
http://www.globenewswire.com/news-release/2021/04/23/2215925/0/en/Knight-Therapeutics-to-Acquire-Regional-Rights-to-Exelon.html
https://www.globenewswire.com/news-release/2021/03/02/2184801/0/en/Knight-Therapeutics-Announces-Canadian-Commercial-Launch-of-IBSRELA-New-Innovative-Treatment-for-Irritable-Bowel-Syndrome-with-Constipation.html
https://www.globenewswire.com/news-release/2020/09/03/2088839/0/en/Knight-Therapeutics-Announces-Filling-of-Supplement-to-a-New-Drug-Submission-for-NERLYNX-neratinib-to-Treat-HER2-Positive-Metastatic-Breast-Cancer.html
https://www.businesswire.com/news/home/20200825005037/en/Knight-TherapeuticsMD-Announce-Health-Canada-Approval-IMVEXXY%C2%AE#:~:text=(NASDAQ%3A%20TXMD)%20(%E2%80%9C,IMVEXXY%C2%AE%20by%20Health%20Canada.&text=Knight%20and%20TherapeuticsMD%20signed%20a,(estradiol%20and%20progesterone)%20capsules.
https://seekingalpha.com/news/3522041-health-canada-review-knights-nds-bijuva
Market Place
Share 
